Advertisement
Screener

Amgen Inc. (AMGN) Expense Breakdown

Amgen Inc. Expense Breakdown

No Expense Breakdown for AMGN on this site yet.

  • 2026-06-30: Reportable $2.14B.
  • 2025-06-30: Reportable $2.48B.

Source checked: the stored Expense Breakdown page for AMGN.

Expenses by product

Cost of sales: each quarter (3 month)

Quarter endReportable
2026-06-30$2.14B
2025-06-30$2.48B

General And Administrative Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$590.00M
2025-06-30$554.00M

Income Tax Expense (Benefit): each quarter (3 month)

Quarter endReportable
2026-06-30$393.00M
2025-06-30$136.00M

Research And Development Expense Software Excluding Acquired In Process Cost: each quarter (3 month)

Quarter endReportable
2026-06-30$1.87B
2025-06-30$1.74B

Selling And Marketing Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$1.16B
2025-06-30$1.14B

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31